US Patent

US8592480 — Liquid compositions of calcium acetate

Method of Use · Assigned to Lyne Labs Inc · Expires 2027-07-20 · 1y remaining

Vulnerability score 80/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects a method for binding phosphorus in the gastrointestinal tract by administering an aqueous solution of calcium acetate.

USPTO Abstract

The invention relates to an aqueous liquid composition of calcium acetate, sweetener, and taste masking agent. Also provided is a method for binding phosphorus within the gastrointestinal tract of an individual by administering to the individual an aqueous solution of at least calcium acetate.

Drugs covered by this patent

Phoslo (CALCIUM ACETATE) · Fresenius Medcl Care

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-1469`	—	Phoslo

Patent Metadata

Patent number: US8592480
Jurisdiction: US
Classification: Method of Use
Expires: 2027-07-20
Drug substance claim: No
Drug product claim: No
Assignee: Lyne Labs Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.